DIAG2TEC
Preclinical hematology research services for biotech and pharmaceutical companies developing treatments for blood cancers
Highlights
- New on EvolcAdded 2026-11-14
About DIAG2TEC
DIAG2TEC is a preclinical contract research organization specializing in hematologic malignancies. It conducts in vitro and ex vivo drug efficacy, resistance and combination assays, and genomic and multi-omics analyses using patient samples and characterized cell models.
Its customers are biotechnology and pharmaceutical companies. Services support treatment evaluation, mechanism-of-action studies, biomarker discovery and patient stratification.
Founded in 2015, DIAG2TEC is headquartered in Montpellier, France. It has been ISO 9001 certified since 2020.
Product: Custom preclinical studies, drug response assays and genomic analyses for hematologic malignancies.
Jobs at DIAG2TEC
Leadership
- Alboukadel Kassambara · Cofounder, Bioinformatic ScientistSource: company website
- Jean-François Dumas · Cofounder, Financial StrategySource: company website
- Jean-Luc Veyrune · Cofounder, Quality processSource: company website
- Jerome Moreaux · Cofounder, CSOSource: company website
- Nicolas Robert · Cofounder, Flow cytometrySource: company website
- Angelique Bruyer · Cofounder, President and CEOSource: company website
More biotech & pharma companies
Diagante
Preanalytical diagnostic device maker for solid tissue and bone/joint infection sample handling in clinical labsNew on EvolcDianosic
Develops long-acting intranasal drug-delivery products for chronic respiratory and central nervous system therapiesNew on EvolcDiogenx
Develops recombinant protein therapies to regenerate insulin-producing beta cells for people with type 1 diabetesDiscngine
Scientific software and tailored IT services for life-science research and early drug discovery teamsDna Gensee
Plant DNA testing and R&D project services for industrial companies using plants or algae in their productsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.